PMA P150003S072

Device
SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System, SYNERGY XD Everolimus-Eluting Platinum Chromium Coro
Applicant
Boston Scientific Corporation
PMA number
P150003
Supplement
S072
Product code
NIQ
Decision date
2021-03-24
Generic name
Coronary drug-eluting stent
Approval order statement
Update the acceptance criteria for the population of white phase precipitate present in platinum chromium alloys (PCA) tubing.

Current openFDA PMA Record#

Device
SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System, SYNERGY XD Everolimus-Eluting Platinum Chromium Coro
Applicant
Boston Scientific Corporation
PMA number
P150003
Supplement
S072
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2021-03-24
Decision code
OK30
Date received
2021-02-26
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Update the acceptance criteria for the population of white phase precipitate present in platinum chromium alloys (PCA) tubing.